Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients
Clinical Pharmacokinetics · 2026-11 · 65 (11) · 1745-1758
DOI: 10.1007/s40262-026-01702-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 22.09.2026. Verfasst von Tianwu Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen,…. Hauptthemen laut MEDLINE: Busulfan, Models, Biological, Machine Learning. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Det Sundhedsvidenskabelige Fakultet, Københavns Universitet, Rigshospitalet, Copenhagen University.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: Busulfan, used in conditioning regimens prior to haematopoietic stem cell transplantation, has a narrow therapeutic index; therefore, due to pharmacokinetic variability, therapeutic drug monitoring (TDM) is employed to ensure drug exposure levels associated with optimal clinical outcomes. This study aimed to facilitate dose adjustment and potentially reduce the number of samples required for TDM in clinical practice. METHODS: Population pharmacokinetic (popPK) and machine learning (ML) models (Random Forest and XGBoost) were developed using a local, retrospective, extensive-sampling dataset of 67 children (637 observations, Denmark) and externally evaluated using prediction error (PE) on a TDM dataset from another centre with 171 children (1871 observations, Netherlands). Limited sampling schedules were evaluated for both methods. RESULTS: A one-compartment model was the best data fit, showing time-varying clearance decreases of 10.4% and 13% on Days 2 and 3, respectively, compared to Day 1. The popPK, Random Forest, and XGBoost models performed well on the external dataset for concentration prediction, with median PE ranging from -4.82 to -7.44%, median absolute PE of approximately 15%, and approximately 80% of data predicted within ±30% of the PE. Sampling strategies at 0, 0.5, 1, 4 h or 0, 1, 2, 4 h post-infusion adequately predicted busulfan plasma concentration and exposure using the popPK model. CONCLUSIONS: A new popPK model was developed to support individualised dose adjustments in children using fewer blood samples. Both Random Forest and XGBoost could predict busulfan's plasma concentration with performance like that of the popPK model (population prediction). However, a larger dataset is needed for ML methods to describe a complete pharmacokinetic profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
- Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark. trine.lund@sund.ku.dk.
Förderung
- Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
- Rigshospitalet
- Copenhagen University
Zitieren
APA
Yang, T., Thastrup, M., Masmas, T. N., Uhlving, H. H., Nersting, J., Petersen, M. J., Rasmussen, A. S. B., Schmiegelow, K., & Lund, T. M. (2026). Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients. Clinical Pharmacokinetics, 65(11), 1745-1758. https://doi.org/10.1007/s40262-026-01702-9
Vancouver
Yang T, Thastrup M, Masmas TN, Uhlving HH, Nersting J, Petersen MJ, et al. Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients. Clinical Pharmacokinetics. 2026;65(11):1745-1758. doi:10.1007/s40262-026-01702-9
BibTeX
@article{Yang2026,
author = {Yang, Tianwu and Thastrup, Maria and Masmas, Tania Nicole and Uhlving, Hilde Hylland and Nersting, Jacob and Petersen, Malene Johanne and Rasmussen, Anna Sofie Buhl and Schmiegelow, Kjeld and Lund, Trine Meldgaard},
title = {Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients},
journal = {Clinical Pharmacokinetics},
year = {2026},
volume = {65},
number = {11},
pages = {1745--1758},
doi = {10.1007/s40262-026-01702-9}
}
EUVIMED